The results reveal that the p-values for all indicators were below 0.05 (p < 0.05), indicating significant inconsistencies, with the exceptions of TGT in OOR and TP therapy; HS and JFK in CD4–CD8; JFK in TCM syndrome; JFK, TGT, and HS in tumor markers; and HS and XK in platelets (p > 0.05) (Supplementary Material S7). The gene discussed is CD4; the disease is neoplasm.